Summary
We describe a patient with acute myeloid leukemia (AML) occurring 5 years after successful treatment of severe aplastic anemia (SAA) with antilymphocyte globulin (ALG). Four years after ALG, SAA had relapsed. A second remission of SAA was achieved, but was followed by transformation of the myelodysplastic syndrome into overt AML. After 2 courses of high-dose cytosine arabinoside and VP-16 complete remission occurred. This case shows that chemotherapy of secondary leukemia after SAA is feasible, and that ex-aplastic bone marrow is capable of complete recovery from chemotherapy-induced aplasia. Morphological anomalies of bone marrow noticed early during remission of SAA might predict a late transformation in leukemia.
References
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199
Bloomfield CD, Brunning RD (1976) Acute leukemia as a a terminal event in nonleukemic hematopoietic disorders. Sem Oncol 3: 297–317
Dessypris EN, Fogo A, Russell M, Engel E, Krantz SB (1980) Studies on pure red cell aplasia. X. Association with acute leukemia and significance of bone marrow karyotype abnormalities. Blood 56: 421–426
Ellims PH, Van der Weyden MB, Brodie GN, Firkin BG, Whiteside MG, Faragher BS (1979) Erythroleukemia following drug induced hypoplastic anemia. Cancer 44: 2140–2146
Fohlmeister I, Fischer R, Moedder B, Rister M, Schaefer HE (1985) Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. J Clin Pathol 38: 1218–1224
Gratwohl A, Osterwalder B, Lori A, Nissen C, Speck B (1985) High dose ARA-C and VP-16 as preconditioning for marrow transplantation before cyclophosphamide and total body irradiation for patients with acute lymphocytic leukemia. Exp Hematol (Suppl 17) 13: 11
Hellriegel KP, Fohlmeister I, Schaefer HE (1979) Aplastic anemia terminating in leukemia. In: Heimpel H, Gordon-Smith EC, Heit W, Kubanek B (eds) Aplastic anemia: Pathophysiology and approaches to therapy. Springer Verlag, Berlin, pp 47 to 51
Herzig RH, Wolff SN, Lazarus HM, Phillips GL, Karanes C, Herzig GP (1983) High-dose Cytosine Arabinoside therapy for refractory leukemia. Blood 62: 361–369
Mir MA, Geary CG (1980) Aplastic anaemia: an analysis of 174 patients. Postgrad Med J 56: 322–329
Mufti GJ, Hamblin TJ, Lee-Potter JP (1983) The aplasialeukaemia syndrome. Aplastic anaemia followed by dyserythropoiesis, myeloproliferative syndrome and acute myeloid leukaemia. Acta Haematol 69: 349–352
Nissen C, Cornu P, Gratwohl A, Speck B (1980) Peripheral blood cells from patients with aplastic anaemia in partial remission suppress growth of their own bone marrow precursors in culture. Br J Haematol 45: 233–243
Nissen C, Gratwohl A, Würsch A, Speck B (1985) Aplastic anemia: A disease of “seed” and “soil”. Exp Hematol (Suppl 17) 13: 64–65
Speck B, Gratwohl A, Nissen C, Leibundgut U, Ruggero D, Osterwalder B, Burri HP, Cornu P, Jeannet M (1981) Treatment of severe aplastic anaemia with antilymphocyte globulin or bone marrow transplantation. Br Med J 282: 860–863
Speck B, Gratwohl A, Nissen C, Osterwalder B, Würsch A, Tichelli A, Lori A, Reusser P, Jeannet M, Signer E (1986) Treatment of severe aplastic anemia. Exp Hematol 14: 126–132
Stivrins TJ, Davis RB, Sanger W, Fritz J, Purtilo DT (1984) Transformation of Fanconi's anemia to acute nonlymphocytic leukemia associated with emergence of Monosomy 7. Blood 64: 173–176
Wasser JS, Yolken R, Miller DR, Diamond L (1978) Congenital hypoplastic anemia (Diamond-Blackfan-Syndrome) terminating in acute myelogenous leukemia. Blood 51: 991–995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tichelli, A., Gratwohl, A., Würsch, A. et al. Secondary leukemia after severe aplastic anemia. Blut 56, 79–81 (1988). https://doi.org/10.1007/BF00633468
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00633468